Company Profile

DSM-Firmenich AG

DSFIR · AMS
Industry
Chemicals & Flavors & Fragrances
Exchange
AMS
Current Price
€85
Jul 4, 2026 close
Fair Buy
≤ €70
Margin-of-safety entry
Baillie Growth Score
40/100
Weak
Intrinsic Value · Three-Tier Range Current price €85 · Within the fair intrinsic-value range

Composite valuation range · conservative €64–€70 / fair €80–€108 / optimistic €121–€135. At €85, Within the fair intrinsic-value range.

Recent developments
Mar 12, 2026 Update Confirmed

dsm-firmenich outlines action plan at Investor Event to accelerate performance, following completion of transformation

At an Investor Event, the company outlined an action plan to accelerate performance after completing transformation.

Possible impact:May affect expectations for synergies, cost efficiency and medium-term growth delivery.

EuronextView source

Automatically summarized from public sources; for context only, not investment advice.

About the company

Company overview coming soon.

Background

History

Coming soonThis section is being filled in — check back soon.

Industry position

Coming soonThis section is being filled in — check back soon.

Research on this stock
40/100 Hold DSM-Firmenich: A Genuine Portfolio Cleanup, Already Priced for the Improvement to Continue DSM-Firmenich is a Swiss-domiciled flavors, fragrances and health-ingredients platform whose 2025 continuing-operations results (sales of EUR 9.03 billion, adjusted EBITDA of EUR 1.77 billion at a 19.6% margin) show a business getting cleaner as it exits Animal Nutrition & Health to CVC for about EUR 2.2 billion, while Perfumery & Beauty carries the group with 8% like-for-like growth in the first quarter of 2026 even as Taste, Texture & Health and Health, Nutrition & Care remain uneven. Rating Hold: the portfolio has genuinely improved faster than the market expected a year ago, but at EUR 85 the price already reflects a fair share of that cleanup, with the ideal buy zone at EUR 64 to 70. DSM-Firmenich AGDSFIR · AMSChemicals & Flavors & FragrancesJul 4, 2026